201 related articles for article (PubMed ID: 8484245)
1. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.
Eriksson L; Shanwell A; Gulliksson H; Högman CF; Svensson LA; Kristensen J; Berg B
Vox Sang; 1993; 64(3):133-8. PubMed ID: 8484245
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
3. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
Högman CF; Eriksson L; Wallvik J; Payrat JM
Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
[TBL] [Abstract][Full Text] [Related]
6. Platelets stored in a glucose-free additive solution or in autologous plasma--an ultrastructural and morphometric evaluation.
Klinger MH; Josch M; Klüter H
Vox Sang; 1996; 71(1):13-20. PubMed ID: 8837351
[TBL] [Abstract][Full Text] [Related]
7. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Porretti L; Murphy S
Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
[TBL] [Abstract][Full Text] [Related]
8. Storage of platelets in additive solutions: effects of phosphate.
Gulliksson H; Larsson S; Kumlien G; Shanwell A
Vox Sang; 2000; 78(3):176-84. PubMed ID: 10838519
[TBL] [Abstract][Full Text] [Related]
9. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
10. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
11. Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluation.
Pietersz RN; Reesink HW; Huijgens PC; van Oers MH
Vox Sang; 1988; 55(3):129-32. PubMed ID: 3070936
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
[TBL] [Abstract][Full Text] [Related]
13. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
14. WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.
van der Meer PF; Pietersz RN; Tiekstra MJ; Huijgens PC; Dekker WJ; Reesink HW
Transfusion; 2001 Jul; 41(7):917-22. PubMed ID: 11452160
[TBL] [Abstract][Full Text] [Related]
15. A system for the supply of platelets suspended in a storage medium including buffy-coat-derived platelet concentrates in combination with "split" apheresis platelets.
Gulliksson H; Larsson S; Shanwell A; Pedajas I; Joie M; Flament J
Transfus Sci; 1997 Mar; 18(1):33-40. PubMed ID: 10174289
[TBL] [Abstract][Full Text] [Related]
16. Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma.
de Wit YES; Vlaar R; Gouwerok E; Hamzeh-Cognasse H; van Mierlo G; Bulder I; Lagerberg JWM; de Korte D; Cognasse F; Ten Brinke A; Zeerleder SS
Blood Transfus; 2023 Mar; 21(2):157-167. PubMed ID: 35302481
[TBL] [Abstract][Full Text] [Related]
17. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
[TBL] [Abstract][Full Text] [Related]
18. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
Larsson S; Sandgren P; Sjödin A; Vesterinen M; Gulliksson H
Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature.
Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M
Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
